Structural Heart Imaging (SHI) Market Overview
The Global Structural Heart Imaging (SHI) Market size is projected at USD 14833.62 million in 2026 and is expected to hit USD 26147.82 million by 2035 with a CAGR of 6.5%.
The Structural Heart Imaging (SHI) Market is being shaped by the increasing use of advanced cardiovascular imaging for diagnosis, treatment planning, procedural guidance, and post-treatment monitoring. Structural heart interventions increasingly depend on detailed visualization of valves, chambers, vessels, and surrounding anatomy, creating sustained demand for high-resolution imaging systems. Echocardiogram is estimated to account for approximately 61% of global SHI demand because of its broad use in routine assessment, pre-procedure evaluation, and real-time guidance. Angiogram contributes about 39%, supported by its importance in catheter-based procedures and anatomical visualization. Approximately 47% of current structural heart imaging demand is associated with intervention planning and procedural support, while around 31% is linked to diagnostic evaluation and follow-up. The increasing complexity of minimally invasive cardiovascular procedures is also encouraging hospitals to invest in imaging capabilities that provide faster visualization, improved anatomical measurements, and more reliable procedural decision-making.
The U.S. Structural Heart Imaging (SHI) Market is supported by high cardiovascular procedure volumes, advanced hospital infrastructure, and growing adoption of minimally invasive structural heart interventions. Adult patients represent approximately 94% of U.S. structural heart imaging demand, reflecting the significantly larger volume of adult valve disease, heart failure, and other structural cardiovascular conditions. Child applications account for nearly 6% of demand but remain important for congenital heart conditions and specialized pediatric cardiac evaluation. Echocardiogram represents an estimated 64% of U.S. SHI utilization, supported by its role in valve assessment, chamber visualization, functional measurements, and procedure guidance, while Angiogram accounts for approximately 36%. Around 42% of U.S. structural heart imaging activity is estimated to be connected with procedural planning or intervention support, increasing demand for imaging systems capable of delivering detailed anatomical information during time-sensitive clinical workflows.
Key Findings
- Market Driver: Growing adoption of minimally invasive structural heart procedures is strengthening imaging demand, with approximately 47% of global SHI utilization linked to procedural planning, guidance, or post-intervention assessment.
- Major Market Restraint: High equipment and infrastructure requirements remain a limitation, with approximately 29% of smaller healthcare facilities facing challenges related to advanced imaging deployment, specialist availability, and workflow integration.
- Emerging Trends: Three-dimensional and real-time cardiac visualization are increasingly influencing clinical workflows, with approximately 34% of advanced SHI programs incorporating enhanced 3D visualization or quantitative imaging capabilities.
- Regional Leadership: North America is expected to maintain a leading position, supported by approximately 38% of global SHI demand and strong adoption of advanced cardiovascular imaging across specialized cardiac centers.
- Competitive Landscape: Competition is increasingly centered on integrated imaging platforms and workflow-oriented technologies, with approximately 26% of major development initiatives emphasizing software enhancement, quantitative analysis, or multimodality integration.
- Market Segmentation: Echocardiogram is expected to remain the leading product type with approximately 61% market share, while Adult applications are projected to dominate demand at nearly 94% of total utilization.
- Recent Development: Increasing adoption of image-guided structural interventions is expanding demand for advanced visualization, with approximately 42% of specialized cardiac imaging activity now associated with procedure planning or real-time intervention support.
Latest Trends
The Structural Heart Imaging (SHI) Market is moving toward higher-resolution, three-dimensional, and workflow-integrated imaging technologies that can support increasingly complex cardiovascular procedures. Approximately 34% of advanced structural heart imaging programs are estimated to incorporate enhanced 3D visualization, quantitative measurements, or advanced reconstruction capabilities. These technologies help clinicians evaluate valve morphology, chamber dimensions, anatomical relationships, and procedural access requirements with greater precision. The trend is particularly important as minimally invasive interventions require detailed anatomical information before and during treatment, increasing the value of imaging systems that can convert complex cardiac anatomy into clinically useful measurements within shorter workflows.
Artificial intelligence and automated image analysis are also becoming important areas of development. Approximately 28% of advanced SHI technology initiatives increasingly incorporate automated measurements, image segmentation, workflow assistance, or decision-support functions. Such capabilities can reduce repetitive analysis and help clinicians identify relevant anatomical characteristics more consistently. Multimodality imaging is another growing trend, with approximately 31% of specialized cardiac centers increasingly combining information from different imaging approaches during complex procedures. This shift is encouraging suppliers to improve interoperability, data management, visualization, and software-based analysis across structural heart workflows.
Market Dynamics
Driver
"Growing minimally invasive cardiac intervention volumes are increasing demand for precise imaging."
The strongest growth driver for the Structural Heart Imaging (SHI) Market is the expanding use of minimally invasive procedures that require detailed anatomical visualization before, during, and after intervention. Approximately 47% of global SHI demand is estimated to be associated with procedural planning, procedural guidance, or follow-up assessment. As clinicians increasingly treat structural cardiovascular conditions through catheter-based techniques, imaging becomes an essential component of the treatment pathway rather than a standalone diagnostic service.
Valve-related procedures are particularly important because treatment decisions depend heavily on accurate anatomical measurements. Approximately 52% of advanced structural heart imaging workflows are estimated to involve valve assessment, including evaluation of morphology, function, chamber dimensions, and surrounding structures. Echocardiogram benefits significantly from this demand because it can provide real-time visualization and functional information during multiple stages of clinical management.
Hospital investment is also supporting adoption. Approximately 36% of specialized cardiovascular facilities are estimated to be increasing their use of advanced imaging capabilities to support more complex structural procedures. This investment is encouraging demand for higher-resolution systems, improved software, quantitative analysis, and integrated imaging workflows capable of handling increasingly sophisticated cardiac interventions.
Restraint
"High system costs and specialist requirements can restrict adoption across smaller facilities."
The major restraint is the cost and complexity associated with advanced structural heart imaging infrastructure. Approximately 29% of smaller or less-specialized healthcare facilities face challenges related to equipment acquisition, maintenance, specialist staffing, and workflow integration. High-end imaging environments may require specialized rooms, supporting infrastructure, trained personnel, and continuous technical maintenance, creating a larger implementation burden than conventional diagnostic systems.
Specialist expertise is another constraint because complex structural heart imaging often requires experienced interpretation and coordination between imaging specialists and interventional teams. Approximately 27% of facilities expanding structural heart capabilities identify specialist availability as a significant operational consideration. Training requirements can also extend deployment timelines when healthcare providers introduce new three-dimensional visualization, advanced measurements, or integrated procedural imaging technologies.
Data management adds another layer of complexity. Approximately 24% of advanced SHI workflows generate increasingly large imaging datasets requiring secure storage, rapid retrieval, and efficient clinical interpretation. Healthcare providers must therefore balance technology adoption with infrastructure capacity, cybersecurity requirements, interoperability, and staff productivity, particularly when multiple imaging systems are incorporated into a single cardiac care pathway.
Opportunity
"Advanced visualization and intelligent image analysis create new clinical opportunities."
Artificial intelligence, automated measurements, and advanced visualization represent significant opportunities for the SHI Market. Approximately 28% of emerging SHI technology initiatives increasingly incorporate software-driven analysis, automated segmentation, or quantitative assessment. These technologies can help clinicians process complex anatomical information more efficiently while supporting consistent measurements across different examinations and procedural stages.
Three-dimensional imaging provides another opportunity because structural heart interventions increasingly require accurate spatial understanding of complex anatomy. Approximately 34% of advanced imaging programs are estimated to use enhanced 3D visualization or reconstruction capabilities. Such technologies can improve treatment planning by allowing clinicians to evaluate anatomical relationships from multiple perspectives rather than relying exclusively on conventional two-dimensional representations.
Child applications also offer a specialized growth opportunity. Although Adult applications dominate with approximately 94% of overall demand, pediatric structural heart imaging requires highly specialized anatomical assessment and represents nearly 6% of market utilization. Continued improvements in image quality, lower examination burden, and specialized pediatric workflows can support greater adoption across congenital and complex childhood cardiac conditions.
Challenge
"Complex cardiac anatomy demands consistently accurate imaging across diverse clinical workflows."
One of the key challenges is achieving consistent imaging quality across patients with substantially different anatomical and physiological characteristics. Approximately 22% of complex structural heart imaging examinations require additional optimization, repeat imaging, or advanced interpretation because of anatomical complexity, motion, or limited visualization. Maintaining reliable image quality is especially important when imaging results directly influence procedural decisions.
Workflow integration is another challenge because structural heart procedures may involve multiple specialists and imaging stages. Approximately 31% of specialized cardiac centers increasingly use multimodality information during complex cases, creating requirements for efficient data transfer, standardized measurements, and coordinated interpretation. Poor integration can increase procedure preparation time and reduce the efficiency benefits expected from advanced imaging technologies.
Technology adoption also requires continuous training because imaging platforms are becoming more sophisticated. Approximately 26% of facilities adopting advanced SHI capabilities require additional staff training related to 3D visualization, quantitative analysis, image reconstruction, or software-assisted workflows. Providers must therefore maintain a balance between technological sophistication and practical usability to ensure that advanced capabilities translate into measurable clinical and operational benefits.
Structural Heart Imaging (SHI) Market Segmentation
By Types
Echocardiogram: Echocardiogram is expected to remain the leading product type in the Structural Heart Imaging (SHI) Market, accounting for approximately 61% of global demand in 2026. Its strong position is supported by broad utilization across structural heart diagnosis, valve assessment, treatment planning, procedural guidance, and post-treatment monitoring. Echocardiographic imaging provides real-time visualization of cardiac structures and functional information, making it particularly valuable when clinicians need immediate anatomical and physiological feedback during structural heart procedures. Approximately 52% of echocardiogram utilization is associated with valve-related assessment and intervention workflows, while another 27% is linked to diagnostic evaluation and follow-up. Growing adoption of three-dimensional echocardiographic capabilities is also strengthening demand, with approximately 34% of advanced cardiac imaging programs incorporating enhanced 3D visualization or quantitative measurements.
Echocardiogram demand is expected to benefit from improvements in image resolution, automated measurements, Doppler capabilities, and software-assisted analysis. Approximately 29% of advanced echocardiography workflows now emphasize automated or semi-automated assessment of cardiac structures, helping reduce repetitive interpretation tasks. The product type is also important across both routine and specialized settings, supporting a broader installed base than highly specialized imaging technologies. By 2035, echocardiogram is expected to maintain a market share of approximately 60%, reflecting its combination of clinical versatility, real-time imaging capability, and suitability for repeated cardiovascular assessment.
Angiogram: Angiogram is estimated to represent approximately 39% of the Structural Heart Imaging (SHI) Market in 2026 and remains an important imaging approach for anatomical visualization during catheter-based cardiovascular procedures. Its role is particularly significant when clinicians need detailed information regarding blood vessels, access pathways, and anatomical relationships associated with structural interventions. Approximately 44% of angiogram utilization is connected with interventional or procedure-support workflows, while around 25% is associated with anatomical assessment before treatment. Continued development of minimally invasive cardiac procedures is supporting demand for imaging systems capable of providing rapid and detailed vascular information.
Angiogram adoption is also benefiting from improvements in digital image processing, image enhancement, and integration with procedural environments. Approximately 32% of specialized angiographic workflows increasingly incorporate advanced visualization or software-based image processing capabilities. Integration with other cardiac imaging information is becoming more important as procedures become technically complex, with approximately 31% of specialized cardiac centers using multimodality information for selected structural heart cases. Angiogram is therefore expected to retain a substantial market position through 2035, with its share remaining near 40% as catheter-based structural interventions continue to expand.
By Applications
Adult: Adult applications are expected to dominate the Structural Heart Imaging (SHI) Market, representing approximately 94% of global demand in 2026. The dominant position reflects the significantly higher incidence of structural cardiovascular conditions among adults, including valve disorders, age-related cardiac abnormalities, and other conditions requiring diagnostic imaging or minimally invasive intervention. Approximately 48% of adult SHI utilization is associated with structural valve assessment and intervention planning, while nearly 29% supports diagnosis, monitoring, or post-procedure evaluation. The growing adoption of catheter-based procedures is further increasing the importance of accurate adult cardiac imaging.
Adult-focused imaging workflows are becoming more sophisticated as cardiovascular interventions increasingly require detailed anatomical measurements and real-time procedural visualization. Approximately 42% of adult structural heart imaging activity is estimated to involve procedure planning or intervention support. Advanced three-dimensional visualization is also gaining importance, with approximately 35% of specialized adult cardiac imaging programs incorporating enhanced 3D capabilities. These developments are encouraging hospitals to invest in imaging systems that combine high-resolution visualization with quantitative analysis and efficient clinical workflows. Adult applications are therefore expected to retain approximately 93% to 95% market share throughout the forecast period.
Child: Child applications account for approximately 6% of the global Structural Heart Imaging (SHI) Market but represent an important specialized segment because pediatric and congenital cardiac conditions often require highly detailed anatomical evaluation. Pediatric imaging can involve complex structural variations that require careful assessment of chambers, valves, vessels, and blood flow. Approximately 58% of child-focused SHI utilization is associated with congenital or structural cardiac evaluation, while around 21% is connected with procedure planning or follow-up assessment.
Technological improvements are creating opportunities for more specialized pediatric imaging workflows. Approximately 26% of pediatric-focused cardiac imaging programs are increasingly adopting enhanced visualization, quantitative assessment, or software-assisted interpretation. Imaging systems designed to provide detailed information while reducing examination complexity can be particularly valuable for younger patients. Although the overall application share remains comparatively small, child-focused SHI demand is expected to increase gradually as specialized pediatric cardiac centers expand advanced imaging capabilities and improve access to structural heart diagnosis and treatment.
Regional Outlook
North America
North America is expected to maintain the leading position in the Structural Heart Imaging (SHI) Market, accounting for approximately 38% of global demand in 2026. The region benefits from established cardiovascular care infrastructure, high adoption of minimally invasive interventions, specialized cardiac centers, and strong utilization of advanced imaging technologies. Approximately 43% of regional SHI activity is associated with procedure planning, intervention support, or post-treatment evaluation, reflecting the growing importance of imaging throughout the structural heart treatment pathway. Echocardiogram represents nearly 63% of regional utilization, supported by its broad application in valve assessment and real-time procedural guidance.
The United States represents the largest demand center within North America, with advanced hospitals increasingly investing in three-dimensional visualization, quantitative imaging, and integrated cardiac workflows. Approximately 34% of specialized U.S. cardiac imaging programs are estimated to incorporate enhanced 3D capabilities, while around 28% are expanding software-assisted analysis. Canada also contributes to regional demand through investments in specialized cardiovascular services and imaging infrastructure. North America is expected to retain a market share of approximately 37% to 39% through the forecast period as structural heart procedure volumes and technology adoption continue to support imaging demand.
Europe
Europe is estimated to account for approximately 28% of the global Structural Heart Imaging (SHI) Market in 2026, supported by established healthcare systems, expanding structural heart programs, and increasing adoption of catheter-based interventions. Approximately 39% of European SHI utilization is associated with procedural planning and intervention support, while around 30% is linked to diagnosis and long-term monitoring. Demand is particularly strong in countries with established cardiac centers and advanced imaging capabilities. Echocardiogram contributes approximately 60% of regional demand, while Angiogram represents nearly 40%.
European healthcare providers are increasingly focused on improving diagnostic accuracy and workflow efficiency. Approximately 31% of specialized cardiac centers in the region are estimated to be increasing adoption of advanced visualization, automated measurements, or integrated imaging solutions. Aging populations are also supporting demand for structural cardiovascular assessment, with approximately 46% of regional imaging activity connected to adult patients requiring evaluation for valve or other structural conditions. Through 2035, Europe is expected to maintain a share close to 27% to 29% as hospitals continue modernizing cardiac imaging capabilities.
Asia-Pacific
Asia-Pacific is expected to be one of the fastest-expanding regional markets, representing approximately 23% of global Structural Heart Imaging (SHI) demand in 2026. Increasing healthcare investment, expansion of specialized cardiac facilities, growing awareness of structural heart disorders, and broader access to minimally invasive procedures are supporting regional adoption. Approximately 36% of regional SHI demand is associated with advanced hospitals and specialized cardiac centers, while another 33% is generated by expanding diagnostic and interventional capabilities in developing healthcare markets.
China, Japan, South Korea, India, and other major Asian markets are contributing to technology adoption through investments in cardiovascular infrastructure and advanced imaging. Approximately 27% of regional SHI programs are estimated to be increasing the use of enhanced visualization or software-based analysis. Adult applications account for approximately 92% of regional demand, while specialized pediatric services contribute around 8%. Asia-Pacific is expected to gradually increase its global market share toward approximately 25% by 2035 as cardiac procedure volumes, healthcare expenditure, and access to advanced imaging continue expanding.
Middle East and Africa
The Middle East and Africa region is estimated to represent approximately 7% of the global Structural Heart Imaging (SHI) Market in 2026. Demand is concentrated in major metropolitan healthcare centers where investment in advanced cardiac diagnosis and intervention is increasing. Approximately 41% of regional SHI activity is associated with specialized hospitals and tertiary cardiac centers, while around 24% is related to diagnostic imaging services. Healthcare modernization programs in several markets are supporting the installation of advanced imaging technologies and expansion of specialist cardiovascular services.
The region continues to face differences in healthcare infrastructure and specialist availability, but investment in advanced cardiovascular care is creating new opportunities. Approximately 22% of specialized cardiac facilities are estimated to be expanding advanced imaging capabilities, including improved visualization and procedural support. Adult applications account for approximately 95% of regional demand, reflecting the dominant role of adult cardiac care. Continued development of specialist hospitals and increasing availability of minimally invasive interventions could raise the region's share toward approximately 8% by 2035.
Rest of World
Rest of World is estimated to contribute approximately 4% of global Structural Heart Imaging (SHI) demand in 2026. This segment includes smaller healthcare markets where adoption is developing through private hospitals, specialized cardiac centers, and targeted healthcare infrastructure investments. Approximately 37% of demand in these markets is associated with specialized facilities offering advanced cardiovascular diagnosis or intervention. Echocardiogram accounts for roughly 62% of regional utilization because of its broad clinical applicability and suitability for different healthcare environments.
Market expansion in Rest of World is increasingly connected with improvements in healthcare access and the gradual introduction of minimally invasive structural heart procedures. Approximately 19% of specialized facilities in these markets are estimated to be adopting enhanced imaging capabilities, while around 26% of demand is connected with procedure planning or monitoring. Although the regional contribution remains comparatively modest, increasing availability of trained specialists and advanced cardiovascular infrastructure could support gradual growth through 2035.
List of Top Structural Heart Imaging (SHI) Companies
- CardioComm Solutions Inc.
- Circle Cardiovascular Imaging, Inc.
- HeartSciences
- Koninklijke Philips N.V.
- Pie Medical Imaging
- Shimadzu Corporation
- Siemens Healthineers
- TomTec Imaging Systems GmbH
- Toshiba Corporation
Top Two Companies with Highest Market Share:
- Koninklijke Philips N.V.: Koninklijke Philips N.V. is estimated to hold approximately 15.8% of the global Structural Heart Imaging (SHI) Market in 2026, supported by its broad cardiovascular ultrasound portfolio, 3D imaging capabilities, intracardiac echocardiography technologies, and integrated solutions for structural heart procedures. Its competitive position is strengthened by products supporting 2D, 3D, and 4D visualization, automated measurements, and image-guided intervention. Approximately 36% of the company's structural heart imaging activity is associated with advanced echocardiographic workflows, while nearly 24% is linked with integrated procedural visualization and image-guided therapy. The company's focus on AI-enabled echocardiography and real-time imaging is also aligned with the market's transition toward more automated and workflow-oriented cardiac imaging.
- Siemens Healthineers: Siemens Healthineers is estimated to account for approximately 14.6% of global SHI demand in 2026, supported by its combination of echocardiography, angiography, multimodality integration, and image-guided cardiovascular technologies. Its structural heart portfolio increasingly connects live ultrasound with fluoroscopic imaging and advanced visualization, supporting complex procedures where accurate anatomical alignment is important. Approximately 33% of its structural heart imaging applications are associated with multimodality or integrated procedural workflows, while around 27% involve advanced echocardiographic visualization. Continued development of AI-supported quantification and integrated imaging platforms is expected to strengthen the company's position as hospitals seek technologies capable of improving procedural consistency and reducing workflow complexity.
Investment Analysis and Opportunities
Investment in the Structural Heart Imaging (SHI) Market is increasingly moving toward technologies that combine high-resolution imaging with automation, artificial intelligence, and procedural guidance. Approximately 35% of current investment priorities across advanced cardiac imaging programs are estimated to focus on software, image analysis, workflow optimization, or multimodality integration rather than hardware improvements alone. This shift reflects the growing importance of extracting clinically useful information from increasingly complex imaging datasets. Healthcare providers are also allocating greater resources to imaging systems that can support both diagnostic evaluation and interventional procedures, helping improve utilization across multiple stages of the cardiac care pathway.
Emerging markets provide another investment opportunity as cardiovascular infrastructure expands and specialized cardiac centers become more widely available. Asia-Pacific is expected to represent approximately 23% of global SHI demand in 2026, creating opportunities for suppliers focused on scalable imaging systems, advanced echocardiography, and software-based analysis. Around 27% of regional structural heart imaging programs are estimated to be increasing adoption of enhanced visualization or automated analysis capabilities. Investment opportunities are also emerging in pediatric cardiac imaging, outpatient cardiac services, and specialized procedural centers, where demand for compact, efficient, and high-quality imaging solutions can support market expansion over the forecast period.
New Product Development
New product development in the Structural Heart Imaging (SHI) Market is increasingly centered on three-dimensional intracardiac echocardiography, AI-assisted measurements, real-time visualization, and integrated image guidance. Approximately 34% of advanced imaging programs are estimated to incorporate enhanced 3D visualization or quantitative analysis, creating strong incentives for manufacturers to improve transducer design, image reconstruction, frame rates, and software functionality. Three-dimensional intracardiac echocardiography is becoming particularly important for structural interventions because it can provide real-time visualization from within the heart while supporting complex procedures involving valves and intracardiac devices. Product development is therefore moving toward systems that deliver clinically relevant information with fewer workflow interruptions.
AI-based automation is another major product development direction, with approximately 28% of advanced SHI technology initiatives incorporating automated segmentation, measurement, image enhancement, or workflow assistance. Developers are increasingly integrating intelligent software directly into echocardiography and angiography platforms rather than treating analytics as separate applications. Multimodality fusion is also gaining importance, with approximately 31% of specialized cardiac centers using information from multiple imaging approaches for selected complex procedures. Future product development is expected to emphasize faster image processing, automated anatomical measurements, real-time device visualization, lower radiation exposure, and improved interoperability between imaging systems.
Five Recent Developments
January 2025 – 3D Intracardiac Imaging Gains Clinical Momentum: Three-dimensional intracardiac echocardiography received greater attention as a structural heart imaging approach for procedures including transseptal puncture, device closure, and transcatheter valve interventions. The technology is increasingly positioned as a complementary or alternative imaging method to conventional transesophageal approaches, supporting the market's movement toward real-time intraprocedural visualization.
April 2026 – AI Advances Reshape Cardiac Imaging Workflows: AI-enabled echocardiography continued gaining importance as imaging providers focused on reducing variability, improving reproducibility, and supporting cardiovascular teams facing increasingly complex workloads. The development trend is encouraging greater use of automated measurements and intelligent workflow tools across structural heart imaging environments.
May 2026 – Integrated Imaging Expands Procedural Guidance: Integrated ultrasound, angiography, physiology, and device-positioning technologies received increased attention for structural heart and interventional procedures. New workflow concepts increasingly combine multiple imaging inputs into a unified procedural environment, supporting faster interpretation and more coordinated decision-making during complex cardiovascular interventions.
June 2026 – Real-Time 3D ICE Demonstrates Clinical Value: Real-time 3D intracardiac echocardiography gained broader visibility as an imaging approach for minimally invasive structural heart procedures. Catheter-based visualization can provide live anatomical information from inside the heart, supporting precise navigation of valves and treatment devices while potentially reducing reliance on more invasive imaging approaches.
June 2026 – AI-Enabled Echocardiography Broadens Adoption: Advanced cardiovascular ultrasound platforms increasingly incorporated automated quantification, intelligent visualization, and workflow-support features for structural heart applications. Some current platforms provide thousands of AI-powered quantifications, illustrating the industry's shift toward software-driven imaging that can support faster examination and more consistent clinical assessment.
Report Coverage
The Structural Heart Imaging (SHI) Market analysis covers market development across Echocardiogram and Angiogram product types and evaluates demand from Adult and Child applications. The assessment considers technology adoption, imaging workflow requirements, procedural guidance, anatomical visualization, software-assisted analysis, and the increasing use of advanced imaging in minimally invasive structural heart interventions. The market outlook covers the period from 2026 to 2035, with global market expansion projected at a CAGR of 6.5% during the forecast period. Approximately 61% of demand is associated with Echocardiogram, while Angiogram contributes about 39%, reflecting the continued importance of both functional cardiac visualization and vascular imaging in structural heart procedures.
The regional assessment covers North America, Europe, Asia-Pacific, Middle East and Africa, and Rest of World, with North America representing approximately 38% of global SHI demand in 2026. The report also evaluates competitive positioning, investment priorities, product development, AI-assisted imaging, three-dimensional visualization, multimodality integration, and recent industry developments. Adult applications account for approximately 94% of total demand, while Child applications represent around 6%. Competitive analysis includes 9 major companies and considers their positioning across imaging technologies, software capabilities, procedural workflows, and advanced cardiac visualization solutions. The analysis further examines market opportunities associated with automated measurements, real-time imaging, image-guided interventions, and the growing integration of intelligent software into structural heart imaging systems.
Structural Heart Imaging (SHI) Market Report Coverage
| REPORT COVERAGE | DETAILS |
|---|---|
| Market Size Value In | USD 14833.62 Million in 2026 |
| Market Size Value By | USD 26147.83 Million by 2035 |
| Growth Rate | CAGR of 6.5% from 2026-2035 |
| Forecast Period | 2026 - 2035 |
| Base Year | 2025 |
| Historical Data Available | Yes |
| Regional Scope | Global |
| Segments Covered |
By Type
Echocardiogram | Angiogram
By Application
Adult | Child
|
Frequently Asked Questions
The Global Structural Heart Imaging (SHI) Market is expected to reach USD 26147.82 million by 2035.
The Structural Heart Imaging (SHI) market is expected to exhibit a CAGR of 6.5% by 2035.
CardioComm Solutions Inc., Circle Cardiovascular Imaging, Inc., HeartSciences, Koninklijke Philips N.V., Pie Medical Imaging, Shimadzu Corporation, Siemens Healthineers, TomTec Imaging Systems GmbH, Toshiba Corporation.
In 2026, the Structural Heart Imaging (SHI) Market value stood at USD 14833.62 million.
Our
Clients